Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial

We evaluated the prognostic and predictive value of a range of molecular changes in the setting of a randomised trial comparing standard PCV (procarbazine, CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) and vincristine) chemotherapy with the standard temozolomide (TMZ) 5-day (200 mg/m(2)/day) s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Acta Neuropathol Commun
Main Authors: Collins, Vincent Peter, Ichimura, Koichi, Di, Ying, Pearson, Danita, Chan, Ray, Thompson, Lindsay C, Gabe, Rhian, Brada, Michael, Stenning, Sally P
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2014
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4229733/
https://ncbi.nlm.nih.gov/pubmed/24952577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-5960-2-68
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares